LFST · XBRL financial data

LifeStance Health Group financial statements, every fiscal year

The same tables from 5 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal years (LFST's year ends in late December)

In millions of dollars	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Revenue	668	860	1,056	1,251	1,424
Revenue from contracts with customers	1	—	—	—	—
Selling, general and administrative	434	378	411	363	382
Total operating expenses	954	1,070	1,245	1,283	1,400
Operating income (loss)	(286)	(210)	(189)	(32)	24
Interest expense	39	20	21	27	12
Income tax expense (benefit)	(26)	(17)	(20)	(0)	3
Net income (loss)	(307)	(216)	(186)	(57)	10
Weighted average shares, basic millions of shares	0	0	0	379	386
Weighted average shares, diluted millions of shares	0	355	0	379	391

Fiscal years (LFST's year ends in late December)

In millions of dollars	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Cash and cash equivalents	148	109	79	155	249
Accounts receivable	76	101	125	132	96
Prepaid and other current assets	42	24	22	26	72
Total current assets	267	233	226	313	416
Property and equipment, net	152	194	188	166	162
Right-of-use asset	0	199	171	148	150
Goodwill	1,205	1,273	1,293	1,293	1,293
Total assets	1,927	2,174	2,110	2,118	2,204
Accounts payable	14	12	7	7	6
Accrued liabilities	27	30	35	47	42
Current portion of long-term debt	1	2	3	7	15
Total current liabilities	117	176	203	229	252
Long-term debt	157	225	280	280	266
Lease liability, non-current	0	213	181	149	149
Total liabilities	382	655	681	672	683
Accumulated deficit	(357)	(573)	(761)	(818)	(809)
Total stockholders' equity	1,545	1,519	1,429	1,446	1,521
Total liabilities and equity	1,927	2,174	2,110	2,118	2,204
Common shares outstanding (cover page) millions of shares	374	376	381	385	390

Fiscal years (LFST's year ends in late December)

In millions of dollars	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Net income (loss)	(307)	(216)	(186)	(57)	10
Stock-based compensation	259	187	99	76	75
Depreciation and amortization	15	29	37	41	42
Net cash from operating activities	9	53	(17)	107	146
Purchases of property and equipment	94	79	41	22	36
Net cash from investing activities	(194)	(139)	(60)	(22)	(36)
Proceeds from long-term debt	99	257	58	288	0
Repayments of long-term debt	311	188	2	289	7
Net cash from financing activities	314	47	47	(10)	(16)
Net change in cash	129	(39)	(30)	76	94

SIC 8000 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 8000 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
A cell reading “not reported” means the filings give no figure for that quarter alone.

Company	Cash ($M)	Revenue, quarter ($M)	Operating cash flow, quarter ($M)	Shares outstanding	Runway	Quarter
LifeStance Health Group	226	435	100*	382.1M	—	Q2 FY26 10-QJun 30, 2026
U S Physical Therapy	25	214	34*	14.9M	—	Q2 FY26 10-QJun 30, 2026
Pennant Group	15	298	22*	34.9M	—	Q2 FY26 10-QJun 30, 2026
Omada Health	222	88	4*	61.2M	—	Q2 FY26 10-QJun 30, 2026
GeneDx Holdings	60	114	(29)*	29.8M	4.6 quarters	Q2 FY26 10-QJun 30, 2026
Talkspace	39	62	11*	165.8M	—	Q2 FY26 10-QJun 30, 2026
Privia Health Group	412	not reported	1.1*	127.7M	—	Q2 FY26 10-QJun 30, 2026
Strata Critical Medical	35	74	9.5*	89.3M	—	Q3 FY26 10-QSep 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.